<DOC>
	<DOCNO>NCT02379000</DOCNO>
	<brief_summary>Proton beam therapy safe irradiation modality choroidal melanoma . But often irradiation exudation increase result exudative retinal detachment require vitreoretinal surgery . It know intravitreally inject triamcinolone TTT capable decrease exudation . If advantage combine treatment study investigate .</brief_summary>
	<brief_title>TTT Versus TTT Triamcinolone Decrease Exudation Choroidal Melanoma After Proton Beam Therapy</brief_title>
	<detailed_description>Proton beam therapy eye preserve irradiation modality uveal melanoma . After proton beam therapy tumor relate lipid exudation exudative retinal detachment often increase . Therefore vitreoretinal surgery sometimes required reattach retina protect visual acuity . It know intravitreally inject triamcinolone TTT capable decrease exudation . If advantage combine treatment effective possibly avoid vitreoretinal surgery study investigate .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Retinal Detachment</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>â€¢exudation ( tumor associate exudation/exudative retinal detachment ) proton beam therapy choroidal melanoma and/or ciliary body melanoma Exclusion criterion : Tumor recurrence Endoresection / previous vitrectomy Treatment antiangiogenic drug intravitreal corticosteroid investigational drug within 3 month prior randomisation Prior laser photocoagulation treatment within 3 month ( focal / grid laser ) 6 month ( panretinal ) prior study entry Known hypersensitivity local anaesthetic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>